Analysts expect Vir Biotechnology, Inc. to report revenue of 812,212.76 for Q3 26, against a range of 735,232.86 to 889,192.66. The most recent reported quarter, Q2 26, came in at 238.95 M, a 79.9% beat against the 132.84 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.38 M | 12.37 M | 3.03 M | 1.21 M | 240,000.00 | 64.07 M | -29,000.00 | 238.95 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 5.89 M | 8.33 M | 8.73 M | 2.77 M | 2.25 M | 22.96 M | 62.54 M | 144.06 M | 889,192.66 | 5.85 M | 37.34 M | 11.72 M | 10.22 M | 29.06 M | 50.09 M | 53.41 M | ||||||||||
| Low Estimate | 4.93 M | 7.60 M | 7.79 M | 2.41 M | 1.90 M | 19.06 M | 55.57 M | 121.61 M | 735,232.86 | 4.90 M | 31.31 M | 10.92 M | 9.27 M | 23.97 M | 47.08 M | 49.75 M | ||||||||||
| Consensus Estimate | 5.41 M | 7.96 M | 8.26 M | 2.59 M | 2.08 M | 21.01 M | 59.06 M | 132.84 M | 812,212.76 | 5.38 M | 34.32 M | 11.32 M | 9.74 M | 26.52 M | 48.59 M | 51.58 M |
Analysts expect Vir Biotechnology, Inc. to report earnings per share of -0.78 for Q3 26, against a range of -0.85 to -0.71. The most recent reported quarter, Q2 26, came in at 0.47, a 34.3% beat against the 0.35 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.56 | -0.76 | -0.88 | -0.80 | -1.17 | -0.31 | -0.85 | 0.47 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.93 | -0.79 | -0.76 | -0.69 | -0.80 | -0.49 | -0.10 | 0.37 | -0.71 | -0.66 | -0.51 | -0.63 | -0.56 | -0.63 | -0.56 | -0.60 | ||||||||||
| Low Estimate | -1.11 | -0.91 | -0.82 | -0.81 | -0.96 | -0.53 | -0.10 | 0.33 | -0.85 | -0.74 | -0.55 | -0.75 | -0.62 | -0.71 | -0.64 | -0.66 | ||||||||||
| Consensus Estimate | -1.02 | -0.85 | -0.79 | -0.75 | -0.88 | -0.51 | -0.10 | 0.35 | -0.78 | -0.70 | -0.53 | -0.69 | -0.59 | -0.67 | -0.60 | -0.63 |
Pull Wall Street consensus for Vir Biotechnology, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VIR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VIR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VIR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();